D455-0408 Screening compound: N~5~-(6-ethoxy-1,3-benzothiazol-2-yl)-6-(4-fluorophenyl)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-imidazo[2,1-b][1,3]thiazole-5-carboxamide

D455-0408 Screening compound: N~5~-(6-ethoxy-1,3-benzothiazol-2-yl)-6-(4-fluorophenyl)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-imidazo[2,1-b][1,3]thiazole-5-carboxamide
D455-0408 Screening compound: N~5~-(6-ethoxy-1,3-benzothiazol-2-yl)-6-(4-fluorophenyl)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-imidazo[2,1-b][1,3]thiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D455-0408
N~5~-(6-ethoxy-1,3-benzothiazol-2-yl)-6-(4-fluorophenyl)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-imidazo[2,1-b][1,3]thiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D455-0408

Molecular Formula

C21H17FN4O4S2 (C21 H17 FN4 O4 S2)

Compound Name

N~5~-(6-ethoxy-1,3-benzothiazol-2-yl)-6-(4-fluorophenyl)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-imidazo[2,1-b][1,3]thiazole-5-carboxamide

IUPAC name

N-(6-ethoxy-13-benzothiazol-2-yl)-6-(4-fluorophenyl)-11-dioxo-2H3H-1lambda6-imidazo[21-b][13]thiazole-5-carboxamide

SMILES

CCOc(cc1)cc2c1nc(NC(c(n1CC3)c(-c(cc4)ccc4F)nc1S3(=O)=O)=O)s2

InChI

InChI=1S/C21H17FN4O4S2/c1-2-30-14-7-8-15-16(11-14)31-20(23-15)25-19(27)18-17(12-3-5-13(22)6-4-12)24-21-26(18)9-10-32(21,28)29/h3-8,11H,2,9-10H2,1H3,(H,23,25,27)

InChI Key

ZVCWPEZCRBLJMD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27587294

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

472.52

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.030

Distribution Coefficient, logD

4.029

Water Solubility, LogSw

-4.01

Polar Surface Area

81.492

Acid Dissociation Constant (pKa)

10.08

Base Dissociation Constant (pKb)

0.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.00

D455-0408 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with D455-0408 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D455-0408?
Check Price and Availability of D455-0408, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D455-0408 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D455-0408
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D455-0408
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D455-0408 available by request